The immunogenicity of the self-peptides that stimulate the Vα3S1/Vβ13S1 TCR for CD8+ T cells from psoriasis patients must now be analyzed in stimulation experiments in a follow-up project. The gene discussed is CD8A; the disease is psoriasis.